AGEN

Agenus Inc. is a biotechnology company focused on the development of immuno-oncology therapies. It specializes in the discovery and commercialization of treatments that harness the immune system to fight cancer. The company operates through various segments, including the development of monoclonal antibodies and other therapeutic agents targeting specific cancer types. Agenus serves a range of customers, including pharmaceutical companies and healthcare providers, primarily in North America and Europe.